US Broker Ratings

Cardinal Health, Inc. (CAH) Stock Analysis: A 20% Upside Potential Beckons Healthcare Investors

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the medical distribution industry, presents a compelling opportunity for investors, with a potential upside of over 20%..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth in Healthcare with Impressive Revenue Expansion

Medpace Holdings, Inc. (NASDAQ: MEDP) is making waves in the healthcare sector with its robust revenue growth and strong market presence. As a key player in..

Elanco Animal Health (ELAN) Stock Analysis: Unveiling 39% Upside Potential in the Thriving Animal Health Sector

Elanco Animal Health Incorporated (NYSE: ELAN) stands out in the bustling healthcare sector as a key player in the animal health industry, offering innovative solutions for..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: 50% Upside Potential Amid Steady Revenue Growth

For investors seeking resilient opportunities in the healthcare sector, Prestige Consumer Healthcare Inc. (PBH) presents a compelling case. This Tarrytown, New York-based company, with a market..

BrightSpring Health Services, I (BTSG) Stock Analysis: Strong Buy Ratings Signal a 39% Upside Potential

BrightSpring Health Services, I (BTSG), a prominent player in the Health Information Services industry, is capturing investor attention with its significant growth potential. Headquartered in Louisville,..

HCA Healthcare, Inc. (HCA) Stock Analysis: Potential Upside and Strategic Insights for Investors

HCA Healthcare, Inc. (NYSE: HCA), a titan in the U.S. healthcare sector, commands a significant presence in the medical care facilities industry. With a market capitalization..

Guardant Health, Inc. (GH) Stock Analysis: A Strong Buy with 9% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a key player in the diagnostics and research industry within the healthcare sector, is making waves with its innovative approach to..

Waystar Holding Corp. (WAY): Investor Outlook on a Healthcare Tech Leader with 30% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY), a prominent player in the healthcare technology space, is capturing the attention of investors with its innovative solutions and promising financial..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook on a Biotech Powerhouse with 27.57% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) stands out in the biotechnology sector, with its focus on developing innovative therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). The company’s flagship..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Promising 37% Upside Potential Amidst Strong Buy Ratings

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a leading player in the biotechnology sector focusing on central nervous system (CNS) disorders, is capturing significant attention from investors. With..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unpacking the 173.67% Return on Equity and Revenue Surge

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has captured investor attention with its impressive financial metrics and strategic partnerships. Headquartered in..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Analyst Ratings and 9% Potential Upside

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the United States’ healthcare sector, continues to capture investor attention with a robust market capitalization of $21.1..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 7.75% Upside Potential Amidst Strategic Collaborations

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a leading global player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, presents a compelling..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Promising 58% Upside Potential in the Biotech Arena

Telix Pharmaceuticals Limited (ASX: TLX), an Australian biopharmaceutical company specializing in radiopharmaceuticals, is capturing investor attention with its impressive potential upside of 58.27% as indicated by..

ADMA Biologics Inc (ADMA) Stock Analysis: Potential Upside of 86.61% Sparks Investor Interest

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, presents a compelling opportunity for investors seeking exposure to the healthcare industry. With a..

Teleflex Incorporated (TFX) Stock Analysis: Potential 23% Upside Amid Strong Revenue Growth

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is capturing investor attention with a notable..

Vaxcyte, Inc. (PCVX) Stock Analysis: An Insight into Its 87.51% Potential Upside

In the dynamic field of biotechnology, Vaxcyte, Inc. (NASDAQ: PCVX) is making significant strides with its innovative approach to vaccine development. As a clinical-stage company, Vaxcyte..

Alkermes plc (ALKS) Stock Analysis: A Look at its 29.88% Potential Upside

Alkermes plc (NASDAQ: ALKS), based in Dublin, Ireland, is a leading player in the healthcare sector, specifically within the drug manufacturers – specialty & generic industry...

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 41% Potential Upside

For investors eyeing opportunities in the healthcare sector, Align Technology, Inc. (NASDAQ: ALGN) offers an intriguing prospect. Known for its innovative Invisalign clear aligners and iTero..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A 9.6% Potential Upside in the Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a global pharmaceutical giant headquartered in Hyderabad, India, continues to stand out in the healthcare sector, specifically within the specialty..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds